FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309530377> ?p ?o ?g. }

• W4309530377 endingPage "e062498" @default.
• W4309530377 startingPage "e062498" @default.
• W4309530377 abstract "Breast cancer survivors treated with adjuvant endocrine therapy commonly experience weight gain, which has been associated with low adherence to therapy and worse breast cancer prognosis. We aim to assess whether a personalised postprandial glucose targeting diet will be beneficial for weight management as compared with the recommended Mediterranean diet in this patient population METHODS AND ANALYSIS: The BREAst Cancer Personalised NuTrition study is a phase-2 randomised trial in hormone receptor positive patients with breast cancer, treated with adjuvant endocrine therapy. The study objective is to assess whether dietary intervention intended to improve postprandial glycaemic response to meals results in better weight and glycaemic control in this population as compared with the standard recommended Mediterranean diet. Consenting participants will be assigned in a single blinded fashion to either of two dietary arms (Mediterranean diet or an algorithm-based personalised diet). They will be asked to provide a stool sample for microbiome analysis and will undergo continuous glucose monitoring for 2 weeks, at the initiation and termination of the intervention period. Microbiome composition data will be used to tailor personal dietary recommendations. After randomisation and provision of dietary recommendations, participants will be asked to continuously log their diet and lifestyle activities on a designated smartphone application during the 6-month intervention period, during which they will be monthly monitored by a certified dietitian. Participants' clinical records will be followed twice yearly for 5 years for treatment adherence, disease-free survival and recurrence.The study has been approved by the ethics committee in the Sheba medical centre (file 5725-18-SMC, Ramat Gan, Israel) and the Weizmann Institutional Review Board (file 693-2, Rehovot, Israel). The findings of this study will be published in a peer reviewed publication.NCT04079270." @default.
• W4309530377 created "2022-11-28" @default.
• W4309530377 creator A5012450539 @default.
• W4309530377 creator A5025393811 @default.
• W4309530377 creator A5028416640 @default.
• W4309530377 creator A5044173386 @default.
• W4309530377 creator A5061202211 @default.
• W4309530377 creator A5066070535 @default.
• W4309530377 creator A5075510824 @default.
• W4309530377 creator A5077267151 @default.
• W4309530377 creator A5079591416 @default.
• W4309530377 creator A5084357214 @default.
• W4309530377 creator A5087833925 @default.
• W4309530377 date "2022-11-01" @default.
• W4309530377 modified "2023-09-25" @default.
• W4309530377 title "BREAst Cancer Personalised NuTrition (BREACPNT): dietary intervention in breast cancer survivors treated with endocrine therapy – a protocol for a randomised clinical trial" @default.
• W4309530377 cites W1551632868 @default.
• W4309530377 cites W1573937225 @default.
• W4309530377 cites W1833172369 @default.
• W4309530377 cites W1929298742 @default.
• W4309530377 cites W1983541741 @default.
• W4309530377 cites W2010028768 @default.
• W4309530377 cites W2016817005 @default.
• W4309530377 cites W2061099728 @default.
• W4309530377 cites W2123931921 @default.
• W4309530377 cites W2136049753 @default.
• W4309530377 cites W2146463166 @default.
• W4309530377 cites W2157802594 @default.
• W4309530377 cites W2167851640 @default.
• W4309530377 cites W2171437158 @default.
• W4309530377 cites W2175465469 @default.
• W4309530377 cites W2202184362 @default.
• W4309530377 cites W2216908918 @default.
• W4309530377 cites W2400867362 @default.
• W4309530377 cites W2463503062 @default.
• W4309530377 cites W2557198675 @default.
• W4309530377 cites W2588601551 @default.
• W4309530377 cites W2595593126 @default.
• W4309530377 cites W2621003427 @default.
• W4309530377 cites W2740616896 @default.
• W4309530377 cites W2753826457 @default.
• W4309530377 cites W2767624550 @default.
• W4309530377 cites W2809324761 @default.
• W4309530377 cites W2907409415 @default.
• W4309530377 cites W2944434778 @default.
• W4309530377 cites W2994666139 @default.
• W4309530377 cites W3094551902 @default.
• W4309530377 cites W3108708190 @default.
• W4309530377 cites W3153195366 @default.
• W4309530377 cites W3184688397 @default.
• W4309530377 cites W3201824943 @default.
• W4309530377 cites W4210940299 @default.
• W4309530377 cites W4240382373 @default.
• W4309530377 doi "https://doi.org/10.1136/bmjopen-2022-062498" @default.
• W4309530377 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36410828" @default.
• W4309530377 hasPublicationYear "2022" @default.
• W4309530377 type Work @default.
• W4309530377 citedByCount "1" @default.
• W4309530377 countsByYear W43095303772023 @default.
• W4309530377 crossrefType "journal-article" @default.
• W4309530377 hasAuthorship W4309530377A5012450539 @default.
• W4309530377 hasAuthorship W4309530377A5025393811 @default.
• W4309530377 hasAuthorship W4309530377A5028416640 @default.
• W4309530377 hasAuthorship W4309530377A5044173386 @default.
• W4309530377 hasAuthorship W4309530377A5061202211 @default.
• W4309530377 hasAuthorship W4309530377A5066070535 @default.
• W4309530377 hasAuthorship W4309530377A5075510824 @default.
• W4309530377 hasAuthorship W4309530377A5077267151 @default.
• W4309530377 hasAuthorship W4309530377A5079591416 @default.
• W4309530377 hasAuthorship W4309530377A5084357214 @default.
• W4309530377 hasAuthorship W4309530377A5087833925 @default.
• W4309530377 hasBestOaLocation W43095303771 @default.
• W4309530377 hasConcept C121608353 @default.
• W4309530377 hasConcept C126322002 @default.
• W4309530377 hasConcept C168563851 @default.
• W4309530377 hasConcept C2908647359 @default.
• W4309530377 hasConcept C511355011 @default.
• W4309530377 hasConcept C530470458 @default.
• W4309530377 hasConcept C535046627 @default.
• W4309530377 hasConcept C544821477 @default.
• W4309530377 hasConcept C71924100 @default.
• W4309530377 hasConcept C99454951 @default.
• W4309530377 hasConceptScore W4309530377C121608353 @default.
• W4309530377 hasConceptScore W4309530377C126322002 @default.
• W4309530377 hasConceptScore W4309530377C168563851 @default.
• W4309530377 hasConceptScore W4309530377C2908647359 @default.
• W4309530377 hasConceptScore W4309530377C511355011 @default.
• W4309530377 hasConceptScore W4309530377C530470458 @default.
• W4309530377 hasConceptScore W4309530377C535046627 @default.
• W4309530377 hasConceptScore W4309530377C544821477 @default.
• W4309530377 hasConceptScore W4309530377C71924100 @default.
• W4309530377 hasConceptScore W4309530377C99454951 @default.
• W4309530377 hasFunder F4320315890 @default.
• W4309530377 hasIssue "11" @default.
• W4309530377 hasLocation W43095303771 @default.
• W4309530377 hasLocation W43095303772 @default.
• W4309530377 hasLocation W43095303773 @default.
• W4309530377 hasOpenAccess W4309530377 @default.

• next